Emory Hematology-Focused (Non-Malignant Hematology) Fellowship Track

Emory University School of Medicine

Haematology & Medical OncologyHaematologySubspecialty training programme
Destination
USA
Atlanta, Georgia, United States

Overview

Single-board non-malignant hematology track supported by the ASH HFFTP, focusing on sickle cell disease, thrombosis and hemostasis and transfusion medicine, using Emory's comprehensive sickle cell and hemostasis/thrombosis centres.

The programme

Focus
Classical haematology
Training type
Subspecialty training programme
Duration
3 years (up to 24 months of clinical or basic/translational research)
Start
1 July
Positions
2 fellows per year (HFFTP track)
Accreditation
Track within the ACGME-accredited Emory Hematology and Medical Oncology Fellowship; leads to ABIM hematology certification eligibility
Department
Not stated on official page

Eligibility and visa

Eligibility
MDs and DOs who completed training in internal medicine or medicine-paediatrics
International applicants
Not stated on official page
Visa support
Not stated on official page
Licence requirement
Not stated on official page

How to apply

Deadline
Fellows selected approximately 7–10 months before the 1 July start (for the July 2025 start, applications opened 1 July 2024)
Application method
ERAS

Funding

Funding
ASH-funded HFFTP: per fellow, ,000/year visiting rotation stipend, ,000/year ASH Annual Meeting stipend and ,500/year scholarly research stipend for three years

Official sources

Similar programmes

More at Emory University